Skip to Main Content

Paper Details

Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Blood
7
2023
ALL, CAR, CAR T-cell, CD19, CD19+, Children, Patients, acute lymphoblastic leukemia, children, lymphoblastic lymphoma, patients, relapsed/refractory (r/r) leukemia
Author NameAffiliation
Yimei LiChildren's Hospital of Philadelphia
Yimei LiCenter for Childhood Cancer Research, Children's Hospital of Philadelphia
Yimei LiUniversity of Pennsylvania Perelman School of Medicine
Carl H JuneParker Institute for Cancer Immunotherapy, University of Pennsylvania
Richard AplencChildren's Hospital of Philadelphia
Richard AplencUniversity of Pennsylvania Perelman School of Medicine
Richard AplencCenter for Childhood Cancer Research, Children's Hospital of Philadelphia
Richard AplencChildren's Hospital of Philadelphia
Richard AplencUniversity of Pennsylvania Perelman School of Medicine
Richard AplencCenter for Childhood Cancer Research, Children's Hospital of Philadelphia
Stephan A GruppChildren's Hospital of Philadelphia
Stephan A GruppUniversity of Pennsylvania Perelman School of Medicine
Stephan A GruppCenter for Childhood Cancer Research, Children's Hospital of Philadelphia
  • 1 - 13

Datasets